You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 205041 - 205050 of 207699 results
  1. DIGITAL FLOW CONTROL FOR AUTOMATION OF PRECISION AGRICULTURAL SPRAYING

    SBC: Capstan Ag Systems, Inc.            Topic: N/A

    INACCURACY IN AGRICULTURAL CHEMICAL APPLICATION CAUSES INCREASED PRODUCTION COSTS AND RELEASES UNNECESSARY PESTICIDE AND FERTILIZERS INTO THE ENVIRONMENT. APPLICATION CONTROL IS PRIMARILY A MANUAL OPERATION AND ON-THE-GO ADJUSTMENT OF SPRAY OUTPUT FOR SPRAY TARGET OR TRAVEL SPEED VARIATION IS RARE. HOWEVER, COMMERCIALIZATION AND USE OF ELECTRONIC SYSTEMS FOR SPEED-BASED APPLICATION CONTROL IS INCR ...

    SBIR Phase II 1995 Department of Agriculture
  2. Attenuated Sporozoite Malaria Vaccine

    SBC: SANARIA INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The recent call for elimination of malaria caused by Plasmodium falciparum and eventual eradication of all malaria has focused attention on this disease, which is responsible for hundreds of millions of cases and a million deaths annually. An ideal tool for eliminating P. falciparum, the causative agent of 99% of all malaria deaths, would be a highly effective ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  3. Selection and preclinical development of a bacteria-targeting, non-antibiotic lead candidate to improve cancer chemotherapy outcomes

    SBC: SYMBERIX, INC.            Topic: 102

    The long-term objective of this project is a therapeutic adjunct to prevent chemotherapy-induced diarrhea (CID) based on a completely new mechanism of action targeting enteric bacteria. This Fast-Track SBIR proposal outlines the strategy for selecting a lead development candidate to be evaluated in investigational new drug (IND)-enabling studies to support a first-in-human trial. The focus of this ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  4. STING Activators as Therapy for Cancer

    SBC: STINGINN, LLC            Topic: 102

    PROJECT SUMMARY The Immuno-oncology (IO) arena affords a new and exciting approach to stimulate the body’s own immune system to fight cancer. The generation of anti-cancer T cells is predominantly triggered by phagocytosed cancer cells stimulating innate immune signaling pathways in professional antigen presenting cells (APC’s). This signaling process is largely governed by STING (stimulator o ...

    STTR Phase II 2022 Department of Health and Human ServicesNational Institutes of Health
  5. Portable Brain Injury Biomarker Detection System with Integrated Microdialysis Pr

    SBC: SFC FLUIDICS, INC.            Topic: 102

    DESCRIPTION provided by applicant Portable Brain Injury Biomarker Detection System with Integrated Microdialysis Probe Project Summary SFC Fluidics is developing a portable fully integrated and automated medical device for clinical monitoring of patients with severe brain injury The instrument will allow for automated detection of several small molecule biomarkers glucose glutamate lact ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. A New Drug Therapy for Advanced Heart Failure

    SBC: CORNOVUS PHARMACEUTICALS INC.            Topic: NHLBI

    PROJECT SUMMARY Current therapy for advanced heart failure (HF) is limited and new treatment is needed since the mortality and morbidity of subjects with this form of heart disease remain high. Effort aimed at enhanced healing of failing heart by cardioprotection represents a novel approach. The specific background for the proposed project is that we have identified the endogenous cardiac P2X rece ...

    SBIR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health
  7. Image guided intervention system for pancreatic cystic lesions

    SBC: PHYSICAL SCIENCES INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This proposal addresses a need for an improved technology for both diagnosis and treatment of patients with cystic neoplasms of the pancreas. Currently, endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) technology is used as a first line of diagnosis for pancreatic lesions. However, the complex regional anatomy of the pancreas and the very difficult ...

    SBIR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  8. EXTENDED RELEASE TORSEMIDE: PHASE 2

    SBC: SARFEZ PHARMACEUTICALS, INC.            Topic: 400

    DESCRIPTION provided by applicant Diuretics are one of the most widely prescribed drugs yet there has been little innovation for decades Patients with congestive heart failure CHF often have chronic kidney disease CKD and retain Na and fluid which causes pulmonary congestion and troublesome lower limb edema Most of these million patients are treated with the loop diuretic furosemide ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. Compartment Syndrome Simulator

    SBC: TOUCH OF LIFE TECHNOLOGIES, INC.            Topic: A05172

    Touch of Life Technologies (ToLTech) proposes to develop a computer-based system to train diagnosis and treatment of Compartment Syndrome (CS) manifested in any muscle compartment of the human body. To do this, ToLTech will utilize its extensive experience building and interacting with virtual anatomy, to produce completely virtual patients exhibiting the look and feel of trauma related to CS. The ...

    SBIR Phase II 2006 Department of DefenseArmy
  10. Dendritic Cell-Targeted HIV Vaccine Product

    SBC: AVANT IMMUNOTHERAPEUTICS, INC.            Topic: NIAID

    DESCRIPTION This proposal is a unique collaboration between a small but full capability biotechnology company and a premier academic institution and laboratory to develop a novel product for clinical trials to prevent HIV infection This proposal describes a vaccine product aimed to provide a feasible and nontoxic way to elicit strong immunity in humans to HIV proteins and it will provide an ad ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government